Anuraag Bukkuri

This paper develops an evolutionary model to show how cancer evolvability affects therapy outcomes, finding that targeted therapy is better for low-evolvability cancers and chemotherapy for high-evolvability ones, with a combined approach effective against facultative evolvability.

The paper identifies two distinct p21-driven pathways to whole-genome duplication in breast cancer cells, both converging on a CDK4/6-dependent polyploid G0 state, and shows that CDK4/6 inhibitors can block WGD and enhance therapy efficacy.

The paper investigates whether adrenergic and mesenchymal phenotypes in neuroblastoma represent distinct cell types or dynamic cell states through theoretical modeling and hypothesis testing.